Human bone marrow-derived mesenchymal stem cell gene expression patterns vary with culture conditions

Background Because of the heterogeneity of human mesenchymal stem cells (MSCs), methods for cell expansion in culture and the effects on gene expression are critical factors that need to be standardized for preparing MSCs. We investigated gene expression patterns of MSCs with different seeding densities and culture times. Methods Bone marrow-derived MSCs were plated at densities from 200 cells/cm2 to 5,000 cells/cm2, and the gene expression patterns were evaluated over time using a reverse-transcription polymerase chain reaction assay. Results The mRNA levels of factors that play a critical role in cell migration and tissue regeneration, such as podocalyxin-like protein (PODXL), α4-integrin, α6-integrin, and leukemia inhibitory factor (LIF), were higher in MSCs plated at 200 cells/cm2 than in MSCs plated at 5,000 cells/cm2. The mRNA levels of these factors gradually increased for 10 days and then decreased by day 15 in culture. MSCs seeded at 200 cells/cm2 that were cultured for 10 days expressed high levels of Oct-4 and Nanog. Indoleamine 2,3-dioxygenase, cyclooxygenase-1, and hepatocyte growth factor expression were upregulated in the presence of the proinflammatory cytokine interferon-γ in these cells. Conclusion We found differences in the gene expression patterns of MSCs under different culture conditions. MSCs from 10-day cultures seeded at a low density were efficiently expanded, expressed PODXL, α6-integrin, α4-integrin, and LIF, and maintained properties like stemness and immunomodulation. Therefore, ex vivo expansion of MSCs maintained for an adequate culture time after plating at low cell density can provide an effective regenerative medicinal strategy for cell therapies using MSCs.

[1]  H. Koo,et al.  Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues. , 2009, Cellular immunology.

[2]  A. Ho,et al.  Heterogeneity of mesenchymal stromal cell preparations. , 2008, Cytotherapy.

[3]  H. Kiem,et al.  Comparison of Mesenchymal Stem Cells from Different Tissues to Suppress T-Cell Activation , 2007, Cell transplantation.

[4]  C. Verfaillie,et al.  Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells. , 2001, Blood.

[5]  D. Prockop,et al.  The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice. , 2009, Blood.

[6]  H. Shimizu,et al.  Mesenchymal Stem Cells Are Recruited into Wounded Skin and Contribute to Wound Repair by Transdifferentiation into Multiple Skin Cell Type1 , 2008, The Journal of Immunology.

[7]  R. Willemze,et al.  Leukemia Inhibitory Factor Induces In Vivo Expansion of Bone Marrow Progenitor Cells that Accelerate Hematopoietic Reconstitution but Do Not Enhance Radioprotection in Lethally Irradiated Mice , 1997, Stem cells.

[8]  D. Emilie,et al.  [Cytokines and autoimmunity]. , 1994, La Revue du praticien.

[9]  J. Andersson,et al.  Endogenous inhibitors of HIV: potent anti-HIV activity of leukemia inhibitory factor. , 2002, Current molecular medicine.

[10]  Paul D. Kessler,et al.  Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.

[11]  R. Pochampally,et al.  A subset of human rapidly self-renewing marrow stromal cells preferentially engraft in mice. , 2006, Blood.

[12]  A. Nauta,et al.  Immunomodulatory properties of mesenchymal stromal cells. , 2007, Blood.

[13]  R. Class,et al.  Propagation and senescence of human marrow stromal cells in culture: a simple colony‐forming assay identifies samples with the greatest potential to propagate and differentiate , 1999, British journal of haematology.

[14]  D J Prockop,et al.  Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Tuan,et al.  Interleukin‐6 maintains bone marrow‐derived mesenchymal stem cell stemness by an ERK1/2‐dependent mechanism , 2009, Journal of cellular biochemistry.

[16]  H. Qian,et al.  Contribution of alpha6 integrins to hematopoietic stem and progenitor cell homing to bone marrow and collaboration with alpha4 integrins. , 2006, Blood.

[17]  S. Islam,et al.  Attributes of adult stem cells , 2009, The Journal of pathology.

[18]  G. Almeida-Porada,et al.  Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero. , 1999, Experimental hematology.

[19]  L. Fouillard,et al.  Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. , 2008, Cellular immunology.

[20]  R. Pochampally,et al.  Isolation of a Highly Clonogenic and Multipotential Subfraction of Adult Stem Cells from Bone Marrow Stroma , 2004, Stem cells.

[21]  S. Perez,et al.  Characterization of the Optimal Culture Conditions for Clinical Scale Production of Human Mesenchymal Stem Cells , 2006, Stem cells.